✦ LIBER ✦

Molecular markers to identify patients at risk for recurrence after primary treatment for prostate cancer

✍ Scribed by Chandan Kumar-Sinha; Arul M Chinnaiyan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostate-specific antigen doubling time

✍ Glenn M Cannon Jr; Patrick C Walsh; Alan W Partin; Charles R Pound 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Genetic Markers to Identify High Risk Pa

✍ Mayumi Fukuda; Kazuhide Higuchi; Hiroshi Yokozaki; Tetsuya Tanigawa; Masatsugu S 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 54 KB

NADiA ProsVue Prostate-specific Antigen

✍ Moul, Judd W.; Lilja, Hans; Semmes, O. John; Lance, Raymond S.; Vessella, Robert 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 230 KB

Use of electronic medical records to ide

✍ Erickstad, L; Reed, G; Bhat, D; Roehrborn, C G; Lotan, Y 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 221 KB

Novel approaches to treat asymptomatic,

✍ Nancy A Dawson; Susan F Slovin 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Willingness to Pay for Prostate Cancer T

✍ Chunyu Li; Steven B. Zeliadt; Ingrid J. Hall; Judith Lee Smith; Donatus U. Ekwue 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 929 KB